Joshua Sabari
13PUBLICATIONS
149CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Jul 01, 2025
Mitigation and management of adverse events associated with amivantamab therapy.Narjust Florez, Nicole R LeBoeuf, Julia Rotow
|Oct 08, 2024
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve <i>EGFR</i>-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial).Xiuning Le, Jyoti D Patel, Elaine Shum
|Jun 10, 2024
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study.Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim
|Apr 08, 2024
Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer.Rona Yaeger, Nataliya V Uboha, Meredith S Pelster
|Feb 08, 2024
Safety and Intracranial Activity of Adagrasib in Patients With <i>KRAS</i><sup>G12C</sup>-Mutated Non-Small-Cell Lung Cancer and Untreated CNS Metastases in the KRYSTAL-1 Trial: A Case Series.Ezra Bernstein, Jia Luo, Kaiwen Wang
|Nov 21, 2023
Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT).Nitin Ohri, Shruti Jolly, Benjamin T Cooper
Pageof 3
Frequent Collaborators
4 joint publications
Pasi A Jänne
4 joint publications
Alexander I Spira
3 joint publications
Natasha B Leighl
3 joint publications
Ji-Youn Han
3 joint publications
Hirak Der-Torossian
3 joint publications
Rachel E Sanborn
2 joint publications
Catherine A Shu
2 joint publications
Tanios S Bekaii-Saab
2 joint publications
Sai-Hong Ignatius Ou
2 joint publications
James Chih-Hsin Yang
